Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income	$ 118,081	$ 102,044
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquired businesses:
Depreciation and amortization	64,239	58,843
Deferred income taxes	12,916	20,487
Loss (gain) on disposition of assets	735	(1,698)
Share-based compensation	15,322	10,227
Non-cash interest expense	1,090	7,405
Non-cash reduction in contingent liabilities	0	(12,500)
(Increase) decrease in:
Receivables, net	(17,900)	(30,073)
Inventories	(92,374)	(110,128)
Other current assets	148	(17,255)
Pre-production and development costs	(6,997)	(16,769)
Increase (decrease) in:
Accounts payable	105,112	(36,116)
Accrued warranties	11,769	9,125
Accrued other liabilities	7,952	(36,475)
Income taxes payable	8,039	(3,776)
Net change in derivative assets and liabilities	11,524	1,578
Other operating activities	(5,742)	2,268
Net cash provided by (used in) operating activities	233,914	(52,813)
Cash flows from investing activities:
Purchases of short-term investments	0	(60,830)
Maturities of short-term investments	10,008	182,302
Acquisitions, net of cash received	(21,274)	(8,836)
Proceeds from asset dispositions	0	3,668
Capital expenditures	(60,829)	(42,608)
Other items, net	254	0
Net cash (used in) provided by investing activities	(71,841)	73,696
Cash flows from financing activities:
Net increase (decrease) in short-term borrowings	17,250	(26)
Borrowings under new credit agreement	0	300,000
Repayment of long-term debt	(15,000)	(400,000)
Debt issuance costs	0	(6,094)
Cash dividends to shareholders	(41,212)	(20,522)
Repurchase of common stock	(84,448)	(5,398)
Share-based compensation	14,085	7,480
Excess tax benefit from share-based compensation	1,404	0
Other items, net	397	(1,246)
Net cash used in financing activities	(107,524)	(125,806)
Effect of exchange rate changes on cash	9,749	13,818
Net increase (decrease) in cash and cash equivalents	64,298	(91,105)
Cash and cash equivalents at beginning of period	454,258	617,356
Cash and cash equivalents at end of period	518,556	526,251
Supplemental disclosure of cash flow information:
Interest paid, net	3,127	4,198
Income taxes paid	4,325	14,122
Non-cash investing activities:
Accrued and contingent acquisition-related liabilities	$ 6,476	$ 288